Kodiak Sciences (KOD) Operating Expenses (2017 - 2026)
Kodiak Sciences (KOD) posted Operating Expenses of $59.8 million for Q1 2026, up 4.05% on a QoQ basis from $57.5 million in Q4 2025, and up 1.19% year-over-year from $59.1 million in Q1 2025.
Kodiak Sciences (KOD) Operating Expenses (2017 - 2026) Analysis & Trends
Kodiak Sciences' Operating Expenses history runs 10 years deep, the most recent figure standing at $59.8 million for Q1 2026.
- Quarterly Operating Expenses rose 1.19% year-over-year to $59.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $235.1 million (up 17.62% YoY) and the FY2025 annual result came in at $234.4 million, up 25.44% from the prior year.
- Operating Expenses was $59.8 million for Q1 2026 at Kodiak Sciences, up from $57.5 million in the prior quarter.
- Across five years, Operating Expenses topped out at $95.8 million in Q1 2022 and bottomed at $46.1 million in Q1 2024.
- A 5-year average of $64.7 million and a median of $59.8 million in 2026 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses jumped 89.42% — and 2024, when it sank 43.44%.
- Kodiak Sciences' Operating Expenses stood at $74.1 million in 2022, then retreated by 14.44% to $63.4 million in 2023, then declined by 27.13% to $46.2 million in 2024, then grew by 24.41% to $57.5 million in 2025, then grew by 4.05% to $59.8 million in 2026.
- Business Quant data shows KOD's Operating Expenses at $59.8 million in Q1 2026, $57.5 million in Q4 2025, and $62.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.10 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -919.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 445.22 Mn |
| 10 | Kodiak Sciences | 2.56 Bn | 2.56 Bn | - | 59.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.78 Mn |
| Dec 31, 2025 | 57.45 Mn |
| Sep 30, 2025 | 62.35 Mn |
| Jun 30, 2025 | 55.51 Mn |
| Mar 31, 2025 | 59.07 Mn |
| Dec 31, 2024 | 46.18 Mn |
| Sep 30, 2024 | 46.63 Mn |
| Jun 30, 2024 | 47.98 Mn |
| Mar 31, 2024 | 46.06 Mn |
| Dec 31, 2023 | 63.37 Mn |
| Sep 30, 2023 | 54.50 Mn |
| Jun 30, 2023 | 84.83 Mn |
| Mar 31, 2023 | 74.62 Mn |
| Dec 31, 2022 | 74.07 Mn |
| Sep 30, 2022 | 79.48 Mn |
| Jun 30, 2022 | 92.07 Mn |
| Mar 31, 2022 | 95.77 Mn |
| Dec 31, 2021 | 93.05 Mn |
| Sep 30, 2021 | 67.54 Mn |
| Jun 30, 2021 | 55.91 Mn |